Search Trials
Conditions
Learn
About

This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.

A Study to Find Out How BIIB141 (Omaveloxolone) is Processed in the Body and to Learn More About Its Safety in Participants With Friedreich's Ataxia Aged 2 to 15 Years Old | MicrobiomeTrials

← Back to trials

NCT06054893

A Study to Find Out How BIIB141 (Omaveloxolone) is Processed in the Body and to Learn More About Its Safety in Participants With Friedreich's Ataxia Aged 2 to 15 Years Old

RecruitingPHASE1INTERVENTIONAL

Trial Details

Start: 2024-07-01Est. Completion: 2030-06-04

Enrollment target: 33 participants

Locations

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

Other microbiome trials you might be interested in

An Open-Label Study of CTI-1601 in Subjects With Friedreich's AtaxiaPhase 2Recruiting

Friedreich Ataxia

An open label study designed to evaluate the safety, PK, PD, and clinical effects of long-term daily administration of C…

Los Angeles, United StatesEst. completion Jan 2027

View Trial →

A Study to Learn About the Effects and Safety of RTA 408 (Omaveloxolone) in People Aged 16 to 40 With Friedreich's AtaxiaPhase 2Completed

Friedreich Ataxia

In this study, researchers are learning more about RTA 408, also known as omaveloxolone, BIIB141, or SKYCLARYS®. The mai…

Los Angeles, United StatesCompleted Oct 31, 2019

View Trial →

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.